Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability
Authors:
- Eik SchillerESEik Schiller
- Ralf BergmannRBRalf Bergmann
- Jens PietzschJPJens Pietzsch
- Bernhard NollBNBernhard Noll
- Antje StergerASAntje Sterger
- Bernd JohannsenBJBernd Johannsen
- Gerd WunderlichGWGerd Wunderlich
- Hans-Jürgen PietzschHPHans-Jürgen Pietzsch
- 29 February 2008
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (2) , 227-232
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Radiolanthanide-Labeled Monoclonal Antibody CC49 for Radioimmunotherapy of Cancer: Biological Comparison of DOTA Conjugates and 149Pm, 166Ho, and 177LuBioconjugate Chemistry, 2006
- Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and SurvivalJournal of Vascular and Interventional Radiology, 2005
- Treatment of hepatocellular carcinoma by means of radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicineApplied Radiation and Isotopes, 2005
- Labeling and biodistribution of different particle materials for radioembolization therapy with 188ReApplied Radiation and Isotopes, 2005
- Selective Internal Radiation Therapy with SIR-Spheres ® in Patients with Nonresectable Liver TumorsCancer Biotherapy and Radiopharmaceuticals, 2005
- Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancerJournal of Surgical Oncology, 2004
- Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude miceNuclear Medicine and Biology, 2004
- Biopolymer albumin for diagnosis and in drug deliveryDrug Development Research, 2003
- Internal radiation therapy for patients with primary or metastatic hepatic cancerCancer, 1998